Successful treatment with oral valganciclovir of primary CMV enterocolitis in a congenitally infected infant

Karina Irizarry, Stefany Honigbaum, Gail Demmler-Harrison, Sara Rippel, Michael Wilsey

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

Cytomegalovirus (CMV) is the most common congenitally acquired viral infection in the United States and is associated with significant morbidity and mortality. Primary CMV enterocolitis is well documented in immunocompromised patients, but remains rare in congenitally acquired infections. There are no universally accepted recommendations for the treatment of CMV enterocolitis in the pediatric population. Case reports show varied dosing and length of treatment of either intravenously administered ganciclovir, orally administered valganciclovir, or a combination of both. We present a congenitally infected infant with primary CMV enterocolitis who was successfully treated with orally administered valganciclovir.

Original languageEnglish (US)
Pages (from-to)437-441
Number of pages5
JournalFetal and Pediatric Pathology
Volume30
Issue number6
DOIs
StatePublished - Nov 10 2011

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Successful treatment with oral valganciclovir of primary CMV enterocolitis in a congenitally infected infant'. Together they form a unique fingerprint.

Cite this